Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Coulter Licenses HCV Technology for MDx Use

NEW YORK (GenomeWeb News) – Beckman Coulter said today that it has licensed certain rights to hepatitis C virus testing from Siemens Healthcare Diagnostics.
 
Beckman said that under the agreement it received rights to develop, manufacture, and sell a quantitative viral load HCV blood test for use on a molecular diagnostics instrument. The firm is developing a next-generation molecular diagnostics platform, called the UniCel DxN, which it plans to launch in 2010.
 
“Routine molecular testing is the fastest growing segment in clinical diagnostics and represents an important part of our growth strategy,” said Beckman Coulter Chairman, President and CEO Scott Garrett in a statement. “The addition of HCV will enhance our infectious disease test menu while furthering our dedication to improving patient health and reducing the cost of care.”
 
Beckman said that it would take a charge of $12 million in the second quarter as a result of the license.
 
Further terms of the agreement were not disclosed.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.